Children born to mothers taking sedative-hypnotic drugs might be at risk for withdrawal indications in the postnatal period. Neonatal flaccidity has also been described in infants born to mothers who received sedative-hypnotic drugs for the duration of pregnancy. Zolpidem tartrate should be employed through pregnancy only When the likely gain outwe